Drug Type Antibody drug conjugate (ADC) |
Synonyms |
Target- |
Mechanism- |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization ADCendo ApSStartup |
Active Organization ADCendo ApSStartup |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Squamous Cell Carcinoma | Preclinical | DK | ADCendo ApSStartup | 01 Nov 2024 |